Social Anxiety Disorder
Topline results show fasedienol nasal spray reduces symptoms in social anxiety disorder
Fasedienol, a nasal spray for treatment of adults with social anxiety disorder, was efficacious and well-tolerated in a phase 3 trial, according to topline results announced in a press release from developer Vistagen.
Safety behavior modification intervention improves social anxiety symptoms
WASHINGTON — In trauma-exposed people with social anxiety, a safety behavior modification intervention more effectively improved anxiety symptoms compared with a modifiable behavior intervention, according to a poster presented here.
Positive data announced in phase 3 study of nasal spray for social anxiety disorder
A biopharmaceutical company has announced positive data from its phase 3 open-label study evaluating the safety and efficacy of intranasal pherine fasedienol for adults diagnosed with social anxiety disorder.
Vistagen to continue phase 3 clinical trial of social anxiety treatment
Vistagen Therapeutics announced the completion of an interim analysis of PALISADE-2, the company’s second phase 3 clinical trial assessing PH94B in adults with social anxiety disorder, and concluded the trial should continue as planned.
FDA says nasal spray for social anxiety disorder lacks abuse potential
The FDA announced that PH94B, VistaGen Therapeutics’ intranasal drug to treat acute social anxiety in adults, lacks the potential for abuse.
Q&A: Managing social anxiety during the COVID-19 pandemic
As the COVID-19 pandemic and measures to curb its spread continue to evolve, social norms and responsibilities also remain in flux, which may place an additional burden on people with social anxiety disorder.
Cognitive behavioral group therapy, mindfulness intervention reduce social anxiety
Two treatments were effective and provided long-term benefits for patients with social anxiety disorder, according to results of a randomized clinical trial published in JAMA Psychiatry.
Internet-delivered CBT efficacious, cost-effective for youths with social anxiety disorder
Cognitive behavioral therapy delivered over the internet was efficacious and cost-effective for children and adolescents with social anxiety disorder, according to results of a randomized clinical trial published in JAMA Psychiatry.
Behavioral inhibition in infancy predicts introverted personality in adulthood
Behavioral inhibition in infancy appeared associated with a reserved, introverted personality in early adulthood, according to results of a prospective longitudinal study published in Proceedings of the National Academy of Sciences.